₹48.4
MRP ₹64.525% off
(Inclusive of all Taxes)
Get Free delivery (₹99)
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
Taking Clopicard AP 75 Tablet together with mifepristone increases the risk of vaginal bleeding in women.
How to manage the interaction:
Although taking Clopicard AP 75 Tablet with mifepristone is not recommended, that would certainly result in interaction, it can be taken if a doctor prescribes it. If you experience prolonged and heavy bleeding, consult a doctor immediately. Do not discontinue any medication without consulting a doctor.
When Selexipag and Clopicard AP 75 Tablet are taken together, the body's ability to break down Selexipag may be reduced.
How to manage the interaction:
Taking Clopicard AP 75 Tablet with Selexipag is not recommended, please consult your doctor before taking it. They can be taken if prescribed by your doctor.
Combining Ketorolac tromethamine with Clopicard AP 75 Tablet can increase the risk of adverse effects.
How to manage the interaction:
Taking Clopicard AP 75 Tablet with Ketorolac tromethamine is not recommended, as it results in an interaction, it can be taken if advised by a doctor. Do not stop using any medications without a doctor’s advice.
Co-administration of Ketorolac and Clopicard AP 75 Tablet may increase the risk of side effects.
How to manage the interaction:
Taking Ketorolac with Clopicard AP 75 Tablet is not recommended but can be taken together if prescribed by a doctor. However, consult a doctor if you experience unusual bleeding or bruising, dizziness, tarry stools, coughing up or vomiting fresh or dried blood, severe headache and weakness. Do not stop using any medications without talking to a doctor.
Taking deferasirox together with Clopicard AP 75 Tablet may increase the risk of gastrointestinal ulcers and bleeding.
How to manage the interaction:
Although taking Clopicard AP 75 Tablet together with Deferasirox has a possibility of interaction, it can be taken if prescribed by your doctor. However, if you experience abdominal pain, bloating, dizziness, lightheadedness, red or black, tarry stools oe headache. Do not discontinue any medication without consulting your doctor.
Taking Pioglitazone with Clopicard AP 75 Tablet can increases the blood levels of Pioglitazone, when these medicines are taken together, you may experience hypoglycemia (low blood sugar).
How to manage the interaction:
Taking Clopicard AP 75 Tablet together with Pioglitazone may lead to interaction, but it can be taken if prescribed by your doctor. Consult a doctor immediately if you experience headache, dizziness, drowsiness, nervousness, weakness, shaking, or sweating. Do not discontinue any medication without consulting the doctor.
Coadministration of Clopicard AP 75 Tablet with Esomeprazole may reduce the effectiveness of Clopicard AP 75 Tablet.
How to manage the interaction:
Taking Clopicard AP 75 Tablet and esomeprazole together possibly has an interaction, but you can take these medications together if your doctor has advised it. Do not stop using any medications without talking to your doctor.
Taking Clopicard AP 75 Tablet together with Panobinostat can increases the risk of bleeding.
How to manage the interaction:
Although taking Clopicard AP 75 Tablet together with panobinostat can result in interaction, it can be taken if prescribed by a doctor. However, consult your doctor immediately if you experience dizziness, lightheadedness, redness or blackness, sticky stools, or severe headache. Do not discontinue any medication without consulting your doctor.
Taking Clopicard AP 75 Tablet with Defibrotide can increase the risk of bleeding.
How to manage the interaction:
Although taking Clopicard AP 75 Tablet and Defibrotide together can cause an interaction, it can be taken if your doctor has suggested it. However, consult a doctor if you experience bleeding, bruising, feeling dizzy or lightheaded, having black or tarry stools, experiencing a severe headache, feeling weak, or having bleeding or vomiting. Do not discontinue any medications without first consulting your doctor.
Taking Clopicard AP 75 Tablet with Tirofiban can make the antiplatelet effects of Tirofiban stronger.
How to manage the interaction:
There may be a possibility of interaction between Tirofiban and Clopicard AP 75 Tablet, but it can be taken if prescribed by a doctor. Do not discontinue any medications without consulting your doctor.
Drug-Food Interactions
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
सावधानी
शराब के सेवन से बचें क्योंकि यह चक्कर आना और रक्तचाप में वृद्धि जैसे दुष्प्रभावों को बदतर बना सकता है।
गर्भावस्था
सावधानी
गर्भावस्था के दौरान क्लोपिकार्ड एपी 75 टैबलेट 15's का उपयोग करने की अनुशंसा नहीं की जाती है क्योंकि यह भ्रूण को प्रभावित कर सकता है। अगर आप गर्भवती होने की योजना बना रही हैं या क्लोपिकार्ड एपी 75 टैबलेट 15's शुरू करने से पहले ही गर्भवती हैं तो कृपया अपने डॉक्टर से सलाह लें।
स्तनपान
सावधानी
क्लोपिकार्ड एपी 75 टैबलेट 15's स्तनपान को कैसे प्रभावित करता है, इस पर सीमित डेटा उपलब्ध है। क्लोपिकार्ड एपी 75 टैबलेट 15's शुरू करने से पहले कृपया अपने डॉक्टर से सलाह लें।
ड्राइविंग
सावधानी
अगर आपको क्लोपिकार्ड एपी 75 टैबलेट 15's का उपयोग करते समय चक्कर आना या उनींदापन महसूस होता है, तो गाड़ी न चलाएं और न ही मशीनरी चलाएं। क्लोपिकार्ड एपी 75 टैबलेट 15's कभी-कभी धुंधली दृष्टि का कारण भी बन सकता है, इसलिए ऐसी स्थितियों में गाड़ी चलाने से बचें। अगर लक्षण लंबे समय तक बने रहते हैं तो चिकित्सा सहायता लें।
जिगर
सावधानी
अगर आपको लीवर की बीमारी या यकृत हानि का कोई इतिहास रहा है तो अपने डॉक्टर को बताएं। क्लोपिकार्ड एपी 75 टैबलेट 15's लिखने से पहले आपका डॉक्टर लाभ और संभावित जोखिमों का आकलन करेगा।
गुर्दा
सावधानी
अगर आपको गुर्दे की बीमारी का कोई इतिहास रहा है तो अपने डॉक्टर को बताएं। क्लोपिकार्ड एपी 75 टैबलेट 15's लिखने से पहले आपका डॉक्टर लाभ और संभावित जोखिमों का आकलन करेगा।
बच्चे
सावधानी
16 साल से कम उम्र के बच्चों के लिए क्लोपिकार्ड एपी 75 टैबलेट 15's की सिफारिश नहीं की जाती है। बच्चों में क्लोपिकार्ड एपी 75 टैबलेट 15's की सुरक्षा और प्रभावकारिता स्थापित नहीं की गई है।
Have a query?
Customers Also Bought
Disclaimer
Author Details
